GAS7 Deficiency Promotes Metastasis in MYCN-driven Neuroblastoma

One of the greatest barriers to curative treatment of neuroblastoma (NB) is its frequent metastatic outgrowth prior to diagnosis, especially in cases driven by amplification of the MYCN oncogene. However, only a limited number of regulatory proteins that contribute to this complex MYCN-mediated proc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res
Autors principals: Dong, Zhiwei, Yeo, Kok Siong, Lopez, Gonzalo, Zhang, Cheng, Eggum, Erin N. Dankert, Rokita, Jo Lynne, Ung, Choong Yong, Levee, Taylor M., Her, Zuag Paj, Howe, Cassie J., Hou, Xiaonan, van Ree, Janine H., Li, Shuai, He, Shuning, Tao, Ting, Fritchie, Karen, Torres-Mora, Jorge, Lehman, Julia S., Meves, Alexander, Razidlo, Gina L., Rathi, Komal S., Weroha, S. John, Look, A. Thomas, van Deursen, Jan M., Li, Hu, Westendorf, Jennifer J., Maris, John M., Zhu, Shizhen
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8178188/
https://ncbi.nlm.nih.gov/pubmed/33602789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-20-1890
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars